Clinical trial

Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in…

NCT00424008 · Organon and Co, Industry · Completed

Key facts

NCT number NCT00424008
Title Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
Official title A 52-Week Efficacy and Safety Non-Inferiority Study of Fluticasone Propionate/Salmeterol 250/50mcg BID Delivered by Dry Powder Inhaler (Diskus) Versus Mometasone Furoate/Formoterol Fumarate 200/10mcg BID Delivered by Pressurized Metered-Dose Inhaler in Persistent Asthmatics Previously Treated With…
Lead sponsor Organon and Co, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Asthma
Intervention type Drug
Interventions Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI
Enrollment 722
Start date Apr 1, 2007
Primary completion Nov 1, 2008
Completion Nov 1, 2008
First posted Jan 18, 2007
Last update posted May 20, 2024

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies